Company Directory > CDMO > Shandong Jincheng Pharmaceutical Group
Shandong Jincheng Pharmaceutical Group is a leading Chinese pharmaceutical and chemical enterprise specializing in the research, development, and manufacturing of pharmaceutical intermediates, Active Pharmaceutical Ingredients (APIs), and finished dosage forms (FDF). The company is globally recognized as the largest production base for cephalosporin side-chain intermediates and bio-fermentation API Glutathione. In recent years, the group has aggressively expanded into synthetic biology and high-barrier complex preparations, notably becoming a major supplier of high-purity synthetic nicotine for the global e-cigarette market. Through its 'Medicine Science Center' (MSC) and partnerships with the Chinese Academy of Sciences, the company integrates big data and computational simulation into its R&D pipeline to develop innovative therapeutics in oncology, gynecology, and anti-infectives.
CLASSIFICATION
Company Type:CDMO
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:API Manufacturing & CDMO
SIZE & FINANCIALS
Employees:1001-5000
Revenue:$470M (3.37B CNY)
Founded:2004
Ownership:public
Status:operating
FUNDING
Stage:Public
Investors:Fosun Pharma (historical), Public Shareholders
STOCK
Exchange:SZSE
Ticker:300233.SZ
Market Cap:$857M
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule, Synthetic Biology, Recombinant proteins, APIs
Active Trials:21
Trial Phases:Phase 1: 8 | Phase 2: 5 | Phase 3: 4 | Phase 4: 4
FDA Approvals:5
EMA Approvals:3
CORPORATE STRUCTURE
Subsidiaries:Beijing Jincheng Taier Pharmaceutical, Shanghai Jincheng Suzhi Pharmaceutical, Shandong Jincheng Bio-Pharmaceutical, Ganjiang Chinese Medicine Innovation Center (Affiliate/R&D Center)
Key Partnerships:Dalian Institute of Chemical Physics (CAS), Chinese Academy of Sciences, Ganjiang Chinese Medicine Innovation Center
COMPETITION
Position:Leader
Competitors:Qilu Pharmaceutical, North China Pharmaceutical Group, Zhejiang Jingxin Pharmaceutical
LEADERSHIP
Key Executives:
Zhao Yeping - Former Chairman (Resigned Dec 2025)
Liang Xinmiao - Chief Scientist / Advisor
Scientific Founders:Liang Xinmiao
LINKS
Website:jcmsc.cn
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Shandong Jincheng Pharmaceutical Group. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.